Investment manager Michael Lamprecht highlights structural funding gaps, regulatory fragmentation, and the need for commercially viable antimicrobial resistance strategies ...
Calidar completes enrollment in a first-in-human study of its 4D Mammography system, advancing a next-generation imaging platform designed to enhance breast cancer detection through molecular-level diagnostics....
Voice-driven technology automates clinical note-taking, reducing administrative burden and improving patient engagement in eye care practices...
α-Sight™ integrates advanced SPECT imaging, radiochemistry, and quantitative analysis to enable precise tracking of alpha-emitting therapies...
AI will soon enable clinicians to predict ovulation and optimize IVF cycle timing, improving outcomes and operational efficiency....
Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research...
A next-generation, once-weekly therapy designed to provide continuous CNP exposure...
A global randomised trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs. anticoagulation alone...
The article summarises the manifold functions of this critical organ, which is not a mere protective barrier but a crucial super-organ...
Huber is a seasoned sales and commercial executive with more than two decades of leadership experience in healthcare and medical device sales...
